Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2012
11/01/2012US20120277161 Inhibition of multiple cell activation pathways
11/01/2012US20120277153 Treating liver diseases
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120277120 Methods for genomic modification
11/01/2012US20120277111 MicroRNA Mediated Neuronal Cell Induction
11/01/2012US20120276636 Method for improving induced pluripotent stem cell generation efficiency
11/01/2012US20120276634 somatic embryogenesis and embryo harvesting and method and apparatus for preparing plant embryos for plant production
11/01/2012US20120276633 Supplying treated exhaust gases for effecting growth of phototrophic biomass
11/01/2012US20120276632 Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
11/01/2012US20120276631 Methods for controlling the galactosylation profile of recombinantly-expressed proteins
11/01/2012US20120276630 Dry powder cells and cell culture reagents and methods of production thereof
11/01/2012US20120276629 Methods for isolating stem cells
11/01/2012US20120276628 Automated systems and methods for isolating regenerative cells from adipose tissue
11/01/2012US20120276627 Synthetic mimics of mir-124
11/01/2012US20120276626 Synthetic surfaces for culturing stem cell derived cardiomyocytes
11/01/2012US20120276625 Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
11/01/2012US20120276624 Methods for identifying factors for differentiating definitive endoderm
11/01/2012US20120276611 Recombinantly modified plasmin
11/01/2012US20120276591 Compositions and Methods for Use for Antibodies Against Sclerostin
11/01/2012US20120276581 Method for preserving cancellous bone samples and preserved cancellous bone tissue
11/01/2012US20120276579 Organic compounds
11/01/2012US20120276573 Nanotube structures, methods of making nanotube structures, and methods of accessing intracellular space
11/01/2012US20120276572 Methods and compositions for identifying and validating modulators of cell fate
11/01/2012US20120276556 Ligating BDCA-2 Protein for the Purpose of Isolating or Modulating Dendritic Cells
11/01/2012US20120276554 Isolation and use of ryanodine receptors
11/01/2012US20120276553 Mesenchymal precursor cell
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276209 Nucleic acid-containing lipid particles and related methods
11/01/2012US20120276203 Collagen matrix for cell therapy
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276190 Therapy with a chimeric molecule and a pro-apoptotic agent
11/01/2012US20120276171 Micelle encapsulation of therapeutic agents
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276147 Ctsp cancer-testis antigens
11/01/2012US20120276133 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276128 HIV Envelope-CD4 Complexes and Hybrids
11/01/2012US20120276125 Novel immunoconjugates
11/01/2012US20120276119 CD37-Binding Molecules and Immunoconjugates Thereof
11/01/2012US20120276112 Anti-factor xi monoclonal antibodies and methods of use thereof
11/01/2012US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells
11/01/2012US20120276086 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
11/01/2012US20120276079 Method of producing recombinant vitamin k dependent proteins
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276076 Arf6 as a new target for treating alzheimer's disease
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276070 Induced Pluripotent Stem Cells and Related Methods
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276065 Dendritic Cell Populations that are Enriched for Cells that Bear the BDCA-1 Antigen
11/01/2012US20120276063 Priming of pluripotent stem cells for neural differentiation
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276046 Anti ganglioside gd3 antibodies and uses thereof
11/01/2012US20120276013 Genetically determined mouse model of resistance to transplantable cancers
11/01/2012US20120276012 Method of Treatment and Screening Method
11/01/2012US20120276011 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120276004 Human myeloid derived suppressor cell cancer markers
11/01/2012US20120275999 Oncolytic rhabdovirus
11/01/2012US20120275997 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2834279A1 Process using exhaust gases for effecting growth of phototrophic biomass
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2834215A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
11/01/2012CA2834207A1 Mirna396 and growth regulating factors for cyst nematode tolerance in plants
11/01/2012CA2834136A1 Anti-b7-h3 antibody
11/01/2012CA2833917A1 Identification of polynucleotides associated with a sample
11/01/2012CA2829974A1 Enhanced transformation of recalcitrant monocots
10/2012
10/31/2012EP2518152A2 Improved halohydrin epoxidase
10/31/2012EP2518148A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME
10/31/2012EP2518141A1 Stem cells derived from the carotid body and uses thereof
10/31/2012EP2518140A1 Dedifferentation of adult mammalian cardiomyocytes into cardiac stem cells
10/31/2012EP2518139A1 Use of indirubin derivatives for producing pluripotent stem cells
10/31/2012EP2517555A1 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein
10/31/2012EP2516653A1 Promoter sequences
10/31/2012EP2516628A1 Treatment of bone fracture
10/31/2012EP2516627A1 Expansion medium for cd34-negative stem cells
10/31/2012EP2516626A2 Differentiation of human embryonic stem cells
10/31/2012EP2516625A2 Differentiation of human embryonic stem cells
10/31/2012EP2516624A1 Cell line 3m
10/31/2012EP2516623A1 Method for culturing adherent cells
10/31/2012EP2516622A2 Enamel matrix derivative-proteins having tissue generating activity
10/31/2012EP2516620A1 Apparatus and method for cell exploitation
10/31/2012EP2516619A1 Device and method for biological sample purification and enrichment
10/31/2012EP2516504A1 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto
10/31/2012EP2515630A2 Genetic markers associated with drought tolerance in maize
10/31/2012DE102011100450A1 Apparatus, useful e.g. for spraying biologically compatible liquids, biologically compatible suspensions, biologically compatible cell suspensions, comprises hollow needle or cannula with hollow pin for separation of liquids or suspensions
10/31/2012CN1461343B 多核苷酸 Polynucleotide
10/31/2012CN102762741A Fluid flow device containing nanotubes and method for cell trafficking using same
10/31/2012CN102762737A Method for manufacturing a pyripyropene
10/31/2012CN102762728A Methods for producing antibody-producing cells that produce desired polypeptides
10/31/2012CN102762720A Subpopulations of spore-like cells and uses thereof
10/31/2012CN102762719A Improved methods of cell culture for adoptive cell therapy
10/31/2012CN102762718A Manipulation of osmolality for differentiating stem cells
10/31/2012CN102762717A Method for constructing chimeric rat using rat embryonic stem cells
10/31/2012CN102762716A Method for optimizing a biopharmaceutical production process
10/31/2012CN102762715A Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof
10/31/2012CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors